In Vitro Effects of Clopidogrel on the Platelet-Subendothelium Interaction, Platelet Thromboxane and Endothelial Prostacyclin Production, and Nitric Oxide Synthesis

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 1, 2004, Pages 74-82

  Arrebola, María Monsalud ^a   De La Cruz, José Pedro ^a   Villalobos, Maria Auxiliadora ^a   Pinacho, Araceli ^a   Guerrero, Ana ^a   Sánchez De La Cuesta, Felipe ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Clopidogrel; Nitric oxide; Platelet subendothelium interaction; Prostacyclin; Thromboxane A2

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; NITRIC OXIDE; PROSTACYCLIN; THIENO[2,3 B]PYRIDINE DERIVATIVE; THROMBOXANE; TICLOPIDINE;

ACETYLATION; ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING; SECONDARY PREVENTION; SUBENDOTHELIUM; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; VASCULAR ENDOTHELIUM;

ADULT; ASPIRIN; BLOOD PLATELETS; CELLS, CULTURED; EPOPROSTENOL; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THROMBOXANE B2; TICLOPIDINE;

EID: 0347594033     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200401000-00012     Document Type: Article

References (27)

1. Caprie Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
2. Hirsh J, Weitz JI. New antithrombotic agents. Lancet. 1999;353:1431-1436.
3. Foster CJ, Prosser DM, Agans JM, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest. 2001;107:1591-1598.
4. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
5. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1975;231:232-235.
6. Lopez-Farré A, Caramelo C, Esteban A, et al. Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation. 1995;91:2080-2088.
7. De La Cruz JP, Blanco E, Sanchez De La Cuesta F. Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol. 2000;397:35-41.
8. De La Cruz JP, Arrebola MM, Guerrero A, et al. Influence of nitric oxide on the in vitro antiaggregant effect of ticlopidine. Vascul Pharmacol. 2002;38:183-186.
9. Savi P, Herbert JM, Pflieger AM, et al. Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel. Biochem Pharmacol. 1992;44:527-532.
10. Weber AA, Reimann S, Schrör K. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro. Br J Pharmacol. 1999;126:415-420.
11. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behaviour in blood. J Pharmacol Methods. 1980;1:135-158.
12. Shibuki K. Detection of nitric oxide by an electrochemical micropobe. A comparison to methods in neuroscience. Neuroprotocols. 1992;1:151-157.
13. Sakariassen KS, Aarts PA, De Groot PG, et al. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med. 1983;102:522-535.
14. Jaffe EA, Nachman RL, Becker CG, et al. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973;147:2745-2756.
15. Hart FD, Huskisson EC. Nonsteroidal anti-inflammatory drugs. Current status and rational therapeutic use. Drugs. 1984;27:232-255.
16. Knudsen JB, Bastain W, Sefton CM, et al. Pharmacokinetics of ticlopidine during chronic oral administration to healthy volunteers and its effects on antipyrine pharmacokinetics. Xenobiotica. 1992;22:579-589.
17. McEwen J, Strauch G, Perles P, et al. Clopidogrel bioavailability: absence of influence of food or antacids. Semin Thromb Hemost. 1999;25:47-50.
18. Herbert JM, Savi P. Non-specific inhibition of ADP-induced platelet antiaggregation by clopidogrel in vitro. Thromb Haemostas. 1999;82:156-157.
19. De La Cruz JP, Moreno A, Martinez-Cerdan E, et al. Effect of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats. Naunyn Schmiedebergs Arch Pharmacol. 2003;367:204-210.
20. Chap H, Simon MF, Douste-Blazy L. Effect of ticlopidine on arachidonic acid metabolism in platelet phospholipids in vitro. J Pharmacol. 1981;30:1463-1468.
21. Lagarde M, Ghazi I, Dechayanne M. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production. Prostaglandins Med. 1979;2:433-439.
22. De La Cruz JP, Camara S, Bellido I, et al. Platelet aggregation in human whole blood after chronic administration of aspirin. Thromb Res. 1987;46:133-140.
23. Moro MA, De Alba J, Cardenas A, et al. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices. Neuropharmacology. 2000;39:1309-1318.
24. De La Cruz JP, Guerrero A, Paniego MJ, et al. Effect of aspirin on prostanoids and nitric oxide production in streptozocin-diabetic rats with ischemic retinopathy. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:96-101.
25. Bossavy JP, Thalamas C, Sagnard L, et al. A double-blink randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans. Blood. 1998;5:1518-1525.
26. Cadroy Y, Bossavy JP, Thalamas C, et al. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation. 2000;101:2823-2828.
27. Roald HE, Barstad RM, Kierulf P, et al. Clopidogrel - a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions. Thromb Haemost. 1994;71:655-662.